Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2021-01-17
Type
Journal Article
Author
Aidan T. Hanrath
Author
Brendan A. I. Payne
Author
Christopher J. A. Duncan
URL
https://www.journalofinfection.com/article/S0163-4453(20)30781-7/abstract
Series
Letter to the Editor
Publication
Journal of Infection
ISSN
0163-4453, 1532-2742
Date
26/12/2020
Extra
Publisher: Elsevier
PMID: 33373652
Journal Abbr
Journal of Infection
DOI
10.1016/j.jinf.2020.12.023
Library Catalog
www.journalofinfection.com
Language
English
Abstract
It has been recently suggested that prior exposure to seasonal coronaviruses might
confer cross-protection against SARS-CoV-2.1 Whether SARS-CoV-2 infection itself confers
immunity to reinfection has not been established. Immunity is probable, at least in
the short term, because reinfections are infrequently reported, despite over 55 million
primary infections occurring worldwide since December 2019.2 Protection against short
term reinfection has been observed in a non-human primate model of SARS-CoV-2.